‘Lets take it to the Aussies’: inside Ebos’s ‘revolutionary’ $1.1 billion deal

‘Lets take it to the Aussies’: inside Ebos’s ‘revolutionary’ $1.1 billion deal
Rewind to 2013. Ebos’s chief executive, Mark Waller (right), and Symbion’s chief executive, Patrick Davies, come together to mark a $1.1b transaction. (Image: NZME)
Rebecca Stevenson
In 2013, listed health and animal care company Ebos swallowed a giant. In June of that year, Ebos shareholders overwhelmingly voted for a $1.1 billion acquisition of pharmaceutical company Symbion, or Zuellig Healthcare Holdings Australia. This deal gave rise to a tagline Ebos still references today, as the largest diversified Australasian marketer, wholesaler and distributor of healthcare, medical and pharmaceutical products. It made Ebos then the third-largest listed company on the NZX, and a dual listing on the ASX followed la...

More Markets

Property companies help boost NZ sharemarket
Markets Market Close

Property companies help boost NZ sharemarket

Ryman Healthcare, Argosy Property and Goodman all saw share-price rises.

Tom Raynel 05 Jun 2025
Genesis takes another step in increasing NZ's battery capacity
Markets

Genesis takes another step in increasing NZ's battery capacity

Grid-scale batteries add to the mix, but questions remain over economic viability.

Ian Llewellyn 05 Jun 2025
NZ sharemarket rises strongly on power company gains
Markets Market Close

NZ sharemarket rises strongly on power company gains

Positive day for Mercury and Meridian as well as a2 Milk despite gloom on global front. 

Tom Raynel 04 Jun 2025